Research programme: inflammation/pain therapy - Jenrin Discovery
Alternative Names: JD-4000 seriesLatest Information Update: 04 Nov 2017
At a glance
- Originator Jenrin Discovery
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Inflammatory bowel diseases; Osteoarthritis; Psoriasis
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for research development in Inflammatory-bowel-disease in USA
- 04 Nov 2017 No recent reports of development identified for research development in Osteoarthritis in USA
- 04 Nov 2017 No recent reports of development identified for research development in Psoriasis in USA